Ernest Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.25 M
- Revenue Growth 96.98%
- Profit Growth -106.70%
- Ebitda 98.17%
- Net Worth -0.94%
- Total Assets 61.47%
About Ernest Pharmaceutical
Ernest Pharmaceutical Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 June 2015 (Nine years and eight months 11 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.25 M.
Amit Rai and Sachin Kasivar serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2015PTC265272
-
Company No.
265272
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Jun 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Ernest Pharmaceutical Private Limited offer?
Ernest Pharmaceutical Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Injection, Disposable & Other Optical Lenses, Lenses, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Surgical & ICU Equipments, Nebulizer Machine & Parts, Eyewear, Sunglasses & Accessories, Eyewear.
Who are the key members and board of directors at Ernest Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Rai
|
Director | 06-Jun-2015 | Current |
|
Sachin Kasivar
|
Director | 06-Jun-2015 | Current |
Financial Performance of Ernest Pharmaceutical.
Ernest Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 96.98% increase. The company also saw a substantial fall in profitability, with a 106.7% decrease in profit. The company's net worth dipped by a decrease of 0.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ernest Pharmaceutical?
In 2022, Ernest Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ole Ori Private LimitedAmit Rai and Sachin Kasivar are mutual person
Charges (Loans)
₹0.25 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Apr 2023 | Others | ₹0.25 M | Open |
How Many Employees Work at Ernest Pharmaceutical?
Ernest Pharmaceutical has a workforce of 2 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ernest Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ernest Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
